On the other hand, potential risk mutations were found in patient #2, such as P513A in MAPT, which was suggested to play a role in progressive non-fluent aphasia, or TREM2 p.P211L, which may be a risk modifier for AD/FTD. The gene discussed is MAPT; the disease is frontotemporal dementia.